Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Conscientiae saúde (Impr.) ; 14(1): 153-160, 31 mar. 2015.
Article in Portuguese | LILACS | ID: biblio-676

ABSTRACT

Introdução: A osteoartrose é a principal causa de limitação da funcionalidade e incapacidade nos idosos. Dentre os tratamentos farmacológicos está a suplementação com sulfato de condroitina. Objetivo: Realizar uma revisão sistemática sobre a influência do sulfato de condroitina na dor e aspectos funcionais associados à osteoartrose. Métodos: Foram utilizados os descritores "osteoarthritis" e "chondroitin". Os artigos foram selecionados de forma independente e cega, por dois pesquisadores. Foram incluídos somente ensaios clínicos primários, escritos na língua portuguesa, inglesa e espanhola entre 2005 a 2013. A escala PEDro foi utilizada como instrumento de avaliação. Resultados: Foram encontrados 1.916 estudos, permanecendo nove artigos para a análise. Dos nove analisados, quatro mostraram a eficácia da suplementação do sulfato de condroitina na redução da dor e da incapacidade funcional, enquanto cinco investigações não mostraram efeitos estatisticamente significantes. Conclusões: A influência do sulfato de condroitina na dor e aspectos funcionais na osteoartrose permanece questionável.


Introduction: Osteoarthritis is the leading cause of limitation of functionality and disability in the elderly. The supplementation with chondroitin sulfate is among the pharmacological treatments. Objective: To conduct a systematic review of the influence of chondroitin sulfate on pain and functional aspects associated with osteoarthritis. Methods: The keywords "osteoarthritis" and "chondroitin" were used. The articles were selected independently and blindly by two researchers. Only primary clinical trial, written in Portuguese, English and Spanish in the period between 2005 to 2013 were included. The PEDro scale was used as an evaluation tool. Results: A total of 1.916 studies with appropriate descriptors were found, and nine of these papers remained for analysis. Of these nine studies analyzed, four showed the effectiveness of supplementation of chondroitin sulfate in reducing pain and functional disability, while five studies showed no statistically significant effects. Conclusions: The influence of chondroitin sulfate in pain and functional aspects in osteoarthritis remains questionable.


Subject(s)
Humans , Osteoarthritis/drug therapy , Chondroitin Sulfates/therapeutic use , Inflammation Mediators/therapeutic use , Osteoarthritis/prevention & control , Causalgia/prevention & control , Causalgia/drug therapy , Analgesia
2.
Belo Horizonte; s.n; 2011. 87 p.
Thesis in Portuguese | LILACS, BBO | ID: lil-715085

ABSTRACT

Ao reconhecer que a resposta hospedeira é um componente da etilogia da doença periodontal, criou-se subsídios para o tratamento de pacientes com fármacos de ação antiinflamatória em conjunto com o tratamento convencional a fim de suprimir o processo inflamatório infeccioso...


Subject(s)
Humans , Male , Female , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Periodontal Diseases/etiology , Periodontal Diseases/therapy , Gingival Crevicular Fluid , Inflammation Mediators/therapeutic use , Matrix Metalloproteinases/therapeutic use
3.
Article in English | IMSEAR | ID: sea-51607

ABSTRACT

Rheumatoid arthritis and periodontitis are widely prevalent diseases and are characterized by tissue destruction due to chronic inflammation. Recently, there is growing evidence that the two diseases share many pathological features. This article reviews their clinical and biological links. However, there are only a limited number of studies in this area, which prevent us from offering clear evidence.


Subject(s)
Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/physiopathology , Bone Density Conservation Agents/therapeutic use , Diphosphonates/therapeutic use , Humans , Immunosuppressive Agents/therapeutic use , Inflammation Mediators/therapeutic use , Periodontitis/complications , Periodontitis/drug therapy , Periodontitis/physiopathology , Tetracyclines/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL